(PRWEB) February 13, 2013

More testimony during the DePuy ASR trial points toward potential problems for Johnson & Johnson. The company’s marketing department allegedly encouraged its sales staff in emails and at a conference to be “ruthless” about selling the later-recalled DePuy ASR hip replacement system, the Rottenstein Law Group reports after reviewing videotaped testimony* given on Feb. 13 at the trial currently underway in Los Angeles.

The Rottenstein Law Group, which finds this ne...

People who underwent hip replacement surgeries would attest that recovery and rehabilitation is never easy for them. Having chronic pain after surgery then is unwelcome. Orthopedic surgeons claim that previous damage on the hip joint account for the pain and it is being compounded by the hip procedure. Unfortunately for those who have received the hip implants manufactured by DePuy Orthopaedics, they would have to suffer from more complications due to the inherent flaws found in two of its AS...

DePuy Orthopaedics, a division of Johnson & Johnson, issued a hip replacement recall in August of 2010 for the company’s Articular Surface Replacement (ASR) Hip Resurfacing System and ASR XL Acetabular total hip replacement, consequently due to data linking these products with substantially high failure rates. A serious condition that has added to the suffering of hip replacement recipients is metallosis.

 

Metallosis results from metal-on-metal friction of the hip implant causing release of ...